Neuralgia Treatment Market By Drug Class(Anticonvulsants (Gabapentinoids), Antidepressants (TCAs, SNRIs), Topical Analgesics (Lidocaine, Capsaicin), Opioid Analgesics, Others (Botulinum Toxin, etc.))By Route of Administration(Oral, Topical, Parenteral (Injectable), Others)By End User(Hospitals, Specialty Clinics (Pain Management), Homecare Settings, Others)By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Table of Content

• 1. Research Methodology and Data Source
  • 1.1. Methodology/Research Approach
  • 1.2. Market Size Estimation
  • 1.3. Market Breakdown and Data Triangulation
  • 1.4. Data Sources
  • 1.5. Secondary Sources
  • 1.6. Primary Sources
• 2. Executive Summary
  • 2.1. Taxonomy
  • 2.2. Global Market Outlook
  • 2.3. Key Facts and Figures
  • 2.4. Major Players in Neuralgia Treatment Market
• 3. Global Market Overview
  • 3.1. Industry Overview
  • 3.2. Segmental Overview
  • 3.3. Regional Overview
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Trends
  • 3.5. Regulatory Framework
  • 3.6. Opportunity Map Analysis
  • 3.7. Opportunity Orbits
  • 3.8. Market Investment Feasibility Index
  • 3.9. PESTLE Analysis
  • 3.10. PORTER’S Five Force Analysis
  • 3.11. Drivers & Restraints Impact Analysis
  • 3.12. Patient Journey Mapping
  • 3.13. Technological Landscape
  • 3.14. Product Life Cycle Analysis
  • 3.15. Value Chain Analysis
    • 3.15.1. List of Raw Material Suppliers
    • 3.15.2. List of Neuralgia Treatment Manufacturers
    • 3.15.3. List of Dealer/Distributors
    • 3.15.4. List of Potential Customers
  • 3.16. Cost Structure Analysis
  • 3.17. Regional Market Share and BPS Analysis
• 4. Macro-economic Factors
• 5. Impact of Current Geopolitical Scenario
• 6. Global Neuralgia Treatment Market Analysis and Forecast, By Drug Class
  • 6.1. Key Findings
  • 6.2. Global Neuralgia Treatment Market Size Value (US$ Bn) Forecast,By Drug Class, 2020-2035
    • 6.2.1. Anticonvulsants (Gabapentinoids)
    • 6.2.2. Antidepressants (TCAs, SNRIs)
    • 6.2.3. Topical Analgesics (Lidocaine, Capsaicin)
    • 6.2.4. Opioid Analgesics
    • 6.2.5. Others (Botulinum Toxin, etc.)
  • 6.3. Global Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
• 7. Global Neuralgia Treatment Market Analysis and Forecast, By Route of Administration
  • 7.1. Key Findings
  • 7.2. Global Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 7.2.1. Oral
    • 7.2.2. Topical
    • 7.2.3. Parenteral (Injectable)
    • 7.2.4. Others
  • 7.3. Global Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
• 8. Global Neuralgia Treatment Market Analysis and Forecast, By End User
  • 8.1. Key Findings
  • 8.2. Global Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 8.2.1. Hospitals
    • 8.2.2. Specialty Clinics (Pain Management)
    • 8.2.3. Homecare Settings
    • 8.2.4. Others
  • 8.3. Global Neuralgia Treatment Market Attractiveness Analysis,By End User
• 9. Global Neuralgia Treatment Market Analysis and Forecast, By Region
  • 9.1. Key Findings
  • 9.2. Global Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Region, 2020-2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Middle East & Africa
    • 9.2.5. Latin America
  • 9.3. Global Neuralgia Treatment Market Attractiveness Analysis, By Region
• 10. North America Neuralgia Treatment Market Analysis and Forecast, 2020-2035
  • 10.1. Key Findings
  • 10.2. North America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 10.3. North America Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
  • 10.4. North America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 10.5. North America Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
  • 10.6. North America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 10.7. North America Neuralgia Treatment Market Attractiveness Analysis, By End User
  • 10.8. North America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 10.9. North America Neuralgia Treatment Market Attractiveness Analysis, By Country
    • 10.9.1. The US Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 10.9.2. The US Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 10.9.3. The US Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 10.9.4. Canada Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 10.9.5. Canada Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 10.9.6. Canada Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 11. Europe Neuralgia Treatment Market Analysis and Forecast, 2020-2035
  • 11.1. Key Findings
  • 11.2. Europe Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 11.3. Europe Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
  • 11.4. Europe Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 11.5. Europe Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
  • 11.6. Europe Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 11.7. Europe Neuralgia Treatment Market Attractiveness Analysis, By End User
  • 11.8. Europe Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 11.9. Europe Neuralgia Treatment Market Attractiveness Analysis, By Country
    • 11.9.1. Germany Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.2. Germany Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.3. Germany Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.4. The U.K. Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.5. The U.K. Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.6. The U.K. Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.7. France Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.8. France Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.9. France Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.10. Spain Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.11. Spain Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.12. Spain Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.13. Italy Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.14. Italy Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.15. Italy Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.16. Russia & CIS Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.17. Russia & CIS Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.18. Russia & CIS Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.19. Rest of Europe Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.20. Rest of Europe Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.21. Rest of Europe Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 12. Asia Pacific Neuralgia Treatment Market Analysis and Forecast, 2020-2035
  • 12.1. Key Findings
  • 12.2. Asia Pacific Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 12.3. Asia Pacific Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
  • 12.4. Asia Pacific Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 12.5. Asia Pacific Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
  • 12.6. Asia Pacific Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 12.7. Asia Pacific Neuralgia Treatment Market Attractiveness Analysis, By End User
  • 12.8. Asia Pacific Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 12.9. Asia Pacific Neuralgia Treatment Market Attractiveness Analysis, By Country
    • 12.9.1. China Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.2. China Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.3. China Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.4. India Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.5. India Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.6. India Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.7. Japan Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.8. Japan Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.9. Japan Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.10. South Korea Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.11. South Korea Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.12. South Korea Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.13. ASEAN Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.14. ASEAN Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.15. ASEAN Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.16. Australia & New Zealand Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.17. Australia & New Zealand Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.18. Australia & New Zealand Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.19. Rest of Asia Pacific Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.20. Rest of Asia Pacific Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.21. Rest of Asia Pacific Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 13. Middle East & Africa Neuralgia Treatment Market Analysis and Forecast, 2020-2035
  • 13.1. Key Findings
  • 13.2. Middle East & Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 13.3. Middle East & Africa Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
  • 13.4. Middle East & Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 13.5. Middle East & Africa Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
  • 13.6. Middle East & Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 13.7. Middle East & Africa Neuralgia Treatment Market Attractiveness Analysis, By End User
  • 13.8. Middle East & Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 13.9. Middle East & Africa Neuralgia Treatment Market Attractiveness Analysis, By Country
    • 13.9.1. GCC Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 13.9.2. GCC Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 13.9.3. GCC Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 13.9.4. South Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 13.9.5. South Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 13.9.6. South Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 13.9.7. Rest of Middle East & Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 13.9.8. Rest of Middle East & Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 13.9.9. Rest of Middle East & Africa Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 14. Latin America Neuralgia Treatment Market Analysis and Forecast, 2020-2035
  • 14.1. Key Findings
  • 14.2. Latin America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 14.3. Latin America Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
  • 14.4. Latin America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 14.5. Latin America Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
  • 14.6. Latin America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 14.7. Latin America Neuralgia Treatment Market Attractiveness Analysis, By End User
  • 14.8. Latin America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 14.9. Latin America Neuralgia Treatment Market Attractiveness Analysis, By Country
    • 14.9.1. Brazil Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 14.9.2. Brazil Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 14.9.3. Brazil Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 14.9.4. Mexico Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 14.9.5. Mexico Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 14.9.6. Mexico Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 14.9.7. Rest of Latin America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 14.9.8. Rest of Latin America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 14.9.9. Rest of Latin America Neuralgia Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 15. Competitive Landscape & Company Profiles
  • 15.1. Market Competition Scenario Analysis, By Company
  • 15.2. Competitor Landscape
  • 15.3. Company Share Analysis
  • 15.4. Company Profiles
    • 15.4.1. Pfizer Inc. (Lyrica)
      • 15.4.1.1. Company Details
      • 15.4.1.2. Business Overview
      • 15.4.1.3. Product Portfolio
      • 15.4.1.4. Financial Insights
      • 15.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.1.6. SWOT Analysis
      • 15.4.1.7. Geographic Footprint
    • 15.4.2. GlaxoSmithKline plc
      • 15.4.2.1. Company Details
      • 15.4.2.2. Business Overview
      • 15.4.2.3. Product Portfolio
      • 15.4.2.4. Financial Insights
      • 15.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.2.6. SWOT Analysis
      • 15.4.2.7. Geographic Footprint
    • 15.4.3. Novartis AG
      • 15.4.3.1. Company Details
      • 15.4.3.2. Business Overview
      • 15.4.3.3. Product Portfolio
      • 15.4.3.4. Financial Insights
      • 15.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.3.6. SWOT Analysis
      • 15.4.3.7. Geographic Footprint
    • 15.4.4. Merck & Co., Inc.
      • 15.4.4.1. Company Details
      • 15.4.4.2. Business Overview
      • 15.4.4.3. Product Portfolio
      • 15.4.4.4. Financial Insights
      • 15.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.4.6. SWOT Analysis
      • 15.4.4.7. Geographic Footprint
    • 15.4.5. Eli Lilly and Company (Cymbalta)
      • 15.4.5.1. Company Details
      • 15.4.5.2. Business Overview
      • 15.4.5.3. Product Portfolio
      • 15.4.5.4. Financial Insights
      • 15.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.5.6. SWOT Analysis
      • 15.4.5.7. Geographic Footprint
    • 15.4.6. Johnson & Johnson
      • 15.4.6.1. Company Details
      • 15.4.6.2. Business Overview
      • 15.4.6.3. Product Portfolio
      • 15.4.6.4. Financial Insights
      • 15.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.6.6. SWOT Analysis
      • 15.4.6.7. Geographic Footprint
    • 15.4.7. Teva Pharmaceutical Industries Ltd
      • 15.4.7.1. Company Details
      • 15.4.7.2. Business Overview
      • 15.4.7.3. Product Portfolio
      • 15.4.7.4. Financial Insights
      • 15.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.7.6. SWOT Analysis
      • 15.4.7.7. Geographic Footprint
    • 15.4.8. Mylan N.V. (Viatris)
      • 15.4.8.1. Company Details
      • 15.4.8.2. Business Overview
      • 15.4.8.3. Product Portfolio
      • 15.4.8.4. Financial Insights
      • 15.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.8.6. SWOT Analysis
      • 15.4.8.7. Geographic Footprint
    • 15.4.9. Sun Pharmaceutical Industries Ltd.
      • 15.4.9.1. Company Details
      • 15.4.9.2. Business Overview
      • 15.4.9.3. Product Portfolio
      • 15.4.9.4. Financial Insights
      • 15.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.9.6. SWOT Analysis
      • 15.4.9.7. Geographic Footprint
    • 15.4.10. Dr. Reddy's Laboratories Ltd.
  • 15.4.10.1. Company Details
    • • 15.4.10.2. Business Overview
      • 15.4.10.3. Product Portfolio
      • 15.4.10.4. Financial Insights
      • 15.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.10.6. SWOT Analysis
      • 15.4.10.7. Geographic Footprint
    • 15.4.11. Cipla Inc.
      • 15.4.11.1. Company Details
      • 15.4.11.2. Business Overview
      • 15.4.11.3. Product Portfolio
      • 15.4.11.4. Financial Insights
      • 15.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.11.6. SWOT Analysis
      • 15.4.11.7. Geographic Footprint
    • 15.4.12. Lupin Limited
      • 15.4.12.1. Company Details
      • 15.4.12.2. Business Overview
      • 15.4.12.3. Product Portfolio
      • 15.4.12.4. Financial Insights
      • 15.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.12.6. SWOT Analysis
      • 15.4.12.7. Geographic Footprint
    • 15.4.13. Hikma Pharmaceuticals PLC
      • 15.4.13.1. Company Details
      • 15.4.13.2. Business Overview
      • 15.4.13.3. Product Portfolio
      • 15.4.13.4. Financial Insights
      • 15.4.13.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.13.6. SWOT Analysis
      • 15.4.13.7. Geographic Footprint
    • 15.4.14. Bausch Health Companies Inc.
      • 15.4.14.1. Company Details
      • 15.4.14.2. Business Overview
      • 15.4.14.3. Product Portfolio
      • 15.4.14.4. Financial Insights
      • 15.4.14.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.14.6. SWOT Analysis
      • 15.4.14.7. Geographic Footprint
    • 15.4.15. Endo International plc
      • 15.4.15.1. Company Details
      • 15.4.15.2. Business Overview
      • 15.4.15.3. Product Portfolio
      • 15.4.15.4. Financial Insights
      • 15.4.15.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.15.6. SWOT Analysis
      • 15.4.15.7. Geographic Footprint

List of Tables

• Table 1: Global Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 2: Global Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 3: Global Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 4: Global Neuralgia Treatment Market Value (US$ Bn), By Region, 2020-2035
• Table 5: North America Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 6: North America Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 7: North America Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 8: North America Neuralgia Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 9: The US Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 10: The US Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 11: The US Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 12: Canada Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 13: Canada Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 14: Canada Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 15: Europe Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 16: Europe Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 17: Europe Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 18: Europe Neuralgia Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 19: Germany Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 20: Germany Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 21: Germany Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 22: The U.K. Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 23: The U.K. Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 24: The U.K. Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 25: France Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 26: France Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 27: France Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 28: Spain Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 29: Spain Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 30: Spain Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 31: Italy Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 32: Italy Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 33: Italy Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 34: Russia & CIS Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 35: Russia & CIS Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 36: Russia & CIS Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 37: Rest of Europe Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 38: Rest of Europe Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 39: Rest of Europe Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 40: Asia Pacific Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 41: Asia Pacific Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 42: Asia Pacific Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 43: Asia Pacific Neuralgia Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 44: China Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 45: China Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 46: China Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 47: India Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 48: India Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 49: India Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 50: Japan Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 51: Japan Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 52: Japan Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 53: South Korea Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 54: South Korea Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 55: South Korea Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 56: ASEAN Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 57: ASEAN Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 58: ASEAN Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 59: Australia & New Zealand Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 60: Australia & New Zealand Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 61: Australia & New Zealand Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 62: Rest of Asia Pacific Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 63: Rest of Asia Pacific Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 64: Rest of Asia Pacific Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 65: Middle East & Africa Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 66: Middle East & Africa Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 67: Middle East & Africa Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 68: Middle East & Africa Neuralgia Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 69: GCC Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 70: GCC Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 71: GCC Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 72: South Africa Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 73: South Africa Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 74: South Africa Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 75: Rest of Middle East & Africa Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 76: Rest of Middle East & Africa Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 77: Rest of Middle East & Africa Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 78: Latin America Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 79: Latin America Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 80: Latin America Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 81: Latin America Neuralgia Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 82: Brazil Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 83: Brazil Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 84: Brazil Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 85: Mexico Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 86: Mexico Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 87: Mexico Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 88: Rest of Latin America Neuralgia Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 89: Rest of Latin America Neuralgia Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 90: Rest of Latin America Neuralgia Treatment Market Value (US$ Bn), By End User, 2020-2035

List of Figures

• Figure 1: Global Neuralgia Treatment Market Value (US$ Bn), 2020-2035
• Figure 2: Global Neuralgia Treatment Market Value Share (%) Analysis, By Drug Class, 2025 & 2035
• Figure 3: Global Neuralgia Treatment Market Value Share (%) Analysis, By Route of Administration, 2025 & 2035
• Figure 4: Global Neuralgia Treatment Market Value Share (%) Analysis, By End User, 2025 & 2035
• Figure 5: Global Neuralgia Treatment Market Value Share (%) Analysis, By Region, 2025 & 2035
• Figure 6: Global Neuralgia Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 7: Global Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
• Figure 8: Global Neuralgia Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 9: Global Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 10: Global Neuralgia Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 11: Global Neuralgia Treatment Market Attractiveness Analysis, By End User
• Figure 12: Global Neuralgia Treatment Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
• Figure 13: Global Neuralgia Treatment Market Attractiveness Analysis, By Region
• Figure 14: North America Neuralgia Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 15: North America Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
• Figure 16: North America Neuralgia Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 17: North America Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 18: North America Neuralgia Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 19: North America Neuralgia Treatment Market Attractiveness Analysis, By End User
• Figure 20: North America Neuralgia Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 21: North America Neuralgia Treatment Market Attractiveness Analysis, By Country
• Figure 22: Europe Neuralgia Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 23: Europe Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
• Figure 24: Europe Neuralgia Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 25: Europe Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 26: Europe Neuralgia Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 27: Europe Neuralgia Treatment Market Attractiveness Analysis, By End User
• Figure 28: Europe Neuralgia Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 29: Europe Neuralgia Treatment Market Attractiveness Analysis, By Country
• Figure 30: Asia Pacific Neuralgia Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 31: Asia Pacific Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
• Figure 32: Asia Pacific Neuralgia Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 33: Asia Pacific Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 34: Asia Pacific Neuralgia Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 35: Asia Pacific Neuralgia Treatment Market Attractiveness Analysis, By End User
• Figure 36: Asia Pacific Neuralgia Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 37: Asia Pacific Neuralgia Treatment Market Attractiveness Analysis, By Country
• Figure 38: Middle East & Africa Neuralgia Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 39: Middle East & Africa Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
• Figure 40: Middle East & Africa Neuralgia Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 41: Middle East & Africa Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 42: Middle East & Africa Neuralgia Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 43: Middle East & Africa Neuralgia Treatment Market Attractiveness Analysis, By End User
• Figure 44: Middle East & Africa Neuralgia Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 45: Middle East & Africa Neuralgia Treatment Market Attractiveness Analysis, By Country
• Figure 46: Latin America Neuralgia Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 47: Latin America Neuralgia Treatment Market Attractiveness Analysis, By Drug Class
• Figure 48: Latin America Neuralgia Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 49: Latin America Neuralgia Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 50: Latin America Neuralgia Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 51: Latin America Neuralgia Treatment Market Attractiveness Analysis, By End User
• Figure 52: Latin America Neuralgia Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 53: Latin America Neuralgia Treatment Market Attractiveness Analysis, By Country